行情

TRVN

TRVN

Trevena
NASDAQ

实时行情|Nasdaq Last Sale

1.220
0.000
0.00%
盘后: 1.230 +0.01 +0.82% 17:35 09/23 EDT
开盘
1.210
昨收
1.220
最高
1.240
最低
1.200
成交量
81.90万
成交额
--
52周最高
3.400
52周最低
1.091
市值
2.01亿
市盈率(TTM)
-4.3790
分时
5日
1月
3月
1年
5年
下一代消毒解决方案超越医疗保健
/PRNewswire/ -- Technology has played a major role in helping medical facilities, organizations and governments fight the pandemic. As a result, government funds were used to provide hospital with further necessary technology. Recently, even though the fea...
PR Newswire - PRF · 8小时前
Trevena 将出席奥本海默 2021 年秋季医疗保健生命科学与医疗技术峰会
CHESTERBROOK, Pa., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced th...
GlobeNewswire · 6天前
今日交易时段有异常期权警报的 8 只医疗保健股
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Unusual trading activity could push option prices to ...
Benzinga · 09/16 17:25
Brief-Imvax 任命 John M. Limongelli 为首席法务官
reuters.com · 09/16 12:08
Trevena 将出席 HC Wainwright 第 23 届年度全球投资会议
CHESTERBROOK, Pa., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced th...
GlobeNewswire · 09/09 11:00
强大的软件在遏制大流行方面发挥着关键作用
/PRNewswire/ -- The pandemic has helped to increase awareness of the importance of maintaining hygiene to avoid transmission of pathogens in healthcare facilities and among the general populous. According to data provided by , the global personal protectiv...
PR Newswire - PRF · 09/08 13:00
Brief-Trevena 于 9 月 3 日表示,已向美国 FDA 提交了 Trv045 的 IND 申请
reuters.com · 09/07 20:49
Brief-Trevena 宣布了两个 Olinvyk® 摘要,强调了 Anesthesiology® 2021 接受的安全数据
reuters.com · 08/30 11:36
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解TRVN最新的财务预测,通过TRVN每股收益,每股净资产,每股现金流等数据分析Trevena近期的经营情况,然后做出明智的投资选择。
分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测TRVN价格均价为5.33,最高价位6.00,最低价为5.00。
EPS
机构持股
总机构数: 107
机构持股: 3,622.45万
持股比例: 22.02%
总股本: 1.65亿
类型机构数股数
增持
21
1,354.22万
建仓
27
198.60万
减持
15
493.82万
平仓
25
291.49万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+1.87%
制药与医学研究
+1.27%
高管信息
Non-Executive Chairman/Independent Director
Leon Moulder
President/Chief Executive Officer/Director
Carrie Bourdow
Chief Financial Officer/Senior Vice President
Barry Shin
Senior Vice President
Mark Demitrack
Senior Vice President
Robert Yoder
Independent Director
Scott Braunstein
Independent Director
Michael Dougherty
Independent Director
Marvin Johnson
Independent Director
Jake Nunn
Independent Director
Anne Phillips
Independent Director
Barbara Yanni
暂无数据
TRVN 简况
Trevena Inc是一家生物制药公司。该公司致力于开发和商业化治疗中枢神经系统(CNS)疾病患者的药物。它正在开发OLINVYK,一种用于成人急性疼痛的G蛋白偏向的MOR配体。它正在开发TRV027,一种用于治疗导致急性呼吸窘迫综合征(ARDS)的急性肺损伤和COVID-19患者的异常凝血的血管紧张素II型1(AT1)受体选择性激动剂。它正在开发 TRV250,一种用于治疗急性偏头痛的G蛋白偏向的δ-阿片受体(DOR)。

微牛提供Trevena Inc(NASDAQ-TRVN)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的TRVN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易TRVN股票基本功能。